Pfizer's Paxlovid not included in China's national insurance

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

TAIPEI, Taiwan: China's health care authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive. Paxlovid, an oral medicine developed by New York-based dru

TAIPEI, Taiwan: China's health care authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive.

Paxlovid, an oral medicine developed by New York-based drugmaker Pfizer, has been widely sought after in China since the country beganand a surge of infections started sweeping through the country. Although it is supposed to be prescribed by medical professionals, that has not stopped people scrambling to purchase it on their own through any means at their disposal - including buying generic Indian versions of the drug through the Internet, according to local media reports.

Health care policymakers can leverage bulk purchases to lower prices in negotiations with pharmaceutical companies that, in turn, can net a steady source of revenue.Related:

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

“China's health care authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive.”

No surprise there it’s crap

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

China says talks to include Paxlovid in its health insurance drug list failThe antiviral drug is currently covered by China's broad healthcare insurance scheme under temporary measures. Read more at straitstimes.com. straits_times Not surprising why it failed. Lol Pfizer sucks
Source: STForeignDesk - 🏆 4. / 71 Read more »

JJ Lin went to Taipei for his 'musical hero' Eric Lin's funeral - Singapore NewsEric Lin died at the age of 62 last Dec 11, 2022 due to liver cirrhosis in the past years. Despite a liver transplant from his son, he was not able to see the light of day two weeks after the surgery.
Source: IndependentSG - 🏆 9. / 63 Read more »

Jack Ma: Alibaba tycoon who soared on China's tech dreams grounded by regulatorsAlibana changed the shopping habits of hundreds of millions, catapulting Mr Ma to international stardom. Read more at straitstimes.com. Nicer way of describing Xi’s Cultural Revolution 2.0.
Source: STForeignDesk - 🏆 4. / 71 Read more »

Business missions, leisure travel between Singapore and China poised to take off as curbs easeConnectivity between the two countries has gradually been re-established. Read more at straitstimes.com. Covid will take off too
Source: straits_times - 🏆 5. / 69 Read more »

How I ended up being one of China’s last ‘quarantinees’By landing in Xiamen, I was hoping to serve just a two-day quarantine, but ended up being isolated in a hotel Read more at straitstimes.com. Creepy.
Source: STForeignDesk - 🏆 4. / 71 Read more »

China on alert for new Covid-19 variant as borders reopen ahead of Spring FestivalNo extreme measures, the government has reiterated, but local officials may curb mobility to prevent massive outbreaks. Read more at straitstimes.com.
Source: STForeignDesk - 🏆 4. / 71 Read more »